Literature DB >> 20429098

Prulifloxacin ECG study.

Maria Teresa Rosignoli, Paolo Dionisio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20429098     DOI: 10.2165/11311700-000000000-00000

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  11 in total

Review 1.  Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development.

Authors:  Vaibhav Salvi; Dilip R Karnad; Gopi Krishna Panicker; Snehal Kothari
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

3.  Does the prulifloxacin ECG study prove cardiac safety of the drug?

Authors:  Marek Malik
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

4.  Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval.

Authors:  M Malik; P Färbom; V Batchvarov; K Hnatkova; A J Camm
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

5.  Effects of prulifloxacin on cardiac repolarization in healthy subjects: a randomized, crossover, double-blind versus placebo, moxifloxacin-controlled study.

Authors:  Maria Teresa Rosignoli; Giorgio Di Loreto; Paolo Dionisio
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

6.  Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk.

Authors:  Pierre Lacroix; William J Crumb; Lucia Durando; Giovanni B Ciottoli
Journal:  Eur J Pharmacol       Date:  2003-09-05       Impact factor: 4.432

7.  Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.

Authors:  Ruth Dixon; Sarah Job; Ruth Oliver; Debra Tompson; John G Wright; Kay Maltby; Ulrike Lorch; Jorg Taubel
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

8.  Variability of heart rate correction methods for the QT interval.

Authors:  Mehul Desai; Lang Li; Zeruesenay Desta; Marek Malik; David Flockhart
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

9.  Effects of three fluoroquinolones on QT analysis after standard treatment courses.

Authors:  James P Tsikouris; Michael J Peeters; Craig D Cox; Gary E Meyerrose; Charles F Seifert
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-01       Impact factor: 1.468

10.  Evaluation of vardenafil and sildenafil on cardiac repolarization.

Authors:  Joel Morganroth; Bernard E Ilson; Bonnie C Shaddinger; Guissou A Dabiri; Bela R Patel; Duane A Boyle; Venkat S Sethuraman; Timothy H Montague
Journal:  Am J Cardiol       Date:  2004-06-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.